Effects of DSP-8658, a Novel Selective Peroxisome Proliferator-activated Receptors a/γ Modulator, on Adipogenesis and Glucose Metabolism in Diabetic Obese Mice-Reference-Cited by-同舟云学术

Effects of DSP-8658, a Novel Selective Peroxisome Proliferator-activated Receptors a/γ Modulator, on Adipogenesis and Glucose Metabolism in Diabetic Obese Mice

Published:2015-05-26 Issue:08 Volume:123 Page:492-499
ISSN:0947-7349
Container-title:Experimental and Clinical Endocrinology & Diabetes
language:en
Short-container-title:Exp Clin Endocrinol Diabetes

Author:

Goto T.¹,Nakayama R.¹,Yamanaka M.¹,Takata M.¹,Takazawa T.²,Watanabe K.¹,Maruta K.³,Nagata R.⁴,Nagamine J.¹,Tsuchida A.⁵,Kato H.⁴

Affiliation:

1. Drug Research Division, Sumitomo Dainippon Pharma Co., Ltd. Osaka, Japan

2. Personnel, Sumitomo Dainippon Pharma Co., Ltd. Osaka, Japan

3. Drug Development Division, Sumitomo Dainippon Pharma Co., Ltd. Tokyo, Japan

4. Center for Drug Discovery and Development National Institute of Biomedical Innovation, Osaka, Japan

5. Global Strategy & Business Development, Sumitomo Dainippon Pharma Co., Ltd. Tokyo, Japan

Publisher

Georg Thieme Verlag KG

Subject

Endocrinology,General Medicine,Endocrinology, Diabetes and Metabolism,Internal Medicine

Link

http://www.thieme-connect.de/products/ejournals/pdf/10.1055/s-0035-1549965.pdf

Cited by 11 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. PPARs (Peroxisome Proliferator-activated Receptors) and Their Agonists in Alzheimer's Disease;Medicinal Chemistry;2024-10

2. Potential for repurposing oral hypertension/diabetes drugs to decrease asthma risk in obesity;Journal of Asthma;2022-07-13

3. A Novel Partial PPARγ Agonist Has Weaker Lipogenic Effect in Adipocytes and Stimulates GLUT4 Translocation in Skeletal Muscle Cells via AMPK-Dependent Signaling;Pharmacology;2021-11-04

4. The Opportunities and Challenges of Peroxisome Proliferator-Activated Receptors Ligands in Clinical Drug Discovery and Development;International Journal of Molecular Sciences;2018-07-27

5. Pharmacological Targets for Correction of Dyslipidemias. Opportunities and Prospects of Therapeutic Use;Biochemistry (Moscow), Supplement Series B: Biomedical Chemistry;2018-04